← Back to Clinical Trials
Recruiting NCT04328181

NCT04328181 Comparison of Imaging Quality Between Spectral Photon Counting Computed Tomography (SPCCT) and Dual Energy Computed Tomography (DECT)

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT04328181
Status Recruiting
Phase
Sponsor Hospices Civils de Lyon
Condition Diabetic Foot Ulcer
Study Type INTERVENTIONAL
Enrollment 339 participants
Start Date 2021-01-29
Primary Completion 2026-01-29

Trial Parameters

Condition Diabetic Foot Ulcer
Sponsor Hospices Civils de Lyon
Study Type INTERVENTIONAL
Phase N/A
Enrollment 339
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2021-01-29
Completion 2026-01-29
Interventions
Spectral Photon Counting Computed Tomography (SPCCT)DECT (Dual Energy CT)

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

This pilot study wants to determine to which extent SPCCT allows obtaining images with improved quality and diagnostic confidence when compared to standard Dual Energy CT (DECT), both with and without contrast agent injection. Depending on the anatomical structures/organs to be visualized during CT examinations, different scanning protocols are performed with quite variable ionizing radiation doses. Therefore, in order to obtain the most extensive and representative results of the improvement in image quality between SPCCT and DECT that will be performed CT imaging on several body regions and structures, including diabetic foot, diabetic calcium coronary scoring, adrenal glands, coronary arteries, lung parenchyma, kidney stones, inner ear, brain and joints, earl/temporal bone, colorectal carcinosis.

Eligibility Criteria

Inclusion Criteria: * Patients presenting following one of following medical conditions: 1. Asymptomatic type 1 or 2 diabetes as regard to cardiovascular risks 2. Diabetic foot ulcer 3. Adrenal glands lesions: Adrenal incidentaloma or hyperaldosteronism or macroadenoma 4. Urinary stone(s) 5. Known Coronary artery disease: Stent imaging or control of calcified plaques 6. Diffuse Interstitial Lung Diseases: Idiopathic Pulmonary Fibrosis, Hypersensitivity Pneumonitis, Ground Glass Opacification, Chronic Thromboembolic Pulmonary Hypertension 7. Conductive hearing loss 8. Brain stroke (late or post thrombectomy) 9. Intracranial arteriovenous malformation treated with coils or Onyx 10. Joints diseases in haemophilia 11. Ear/temporal bone 12. Colorectal carcinosis 13. Dissection aortique de type A opérée ou de type B non opérée, hématome intramural * Patient has accepted to participate to the study and has signed the written consent; * Pre-menopausal women only: Negative urinary pregnancy tes

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology